as on September 13, 2025 at 1:29 am IST
Day's Low
Day's High
0.96%
Downside
2.88%
Upside
52 Week's Low
52 Week's High
23.08%
Downside
132.97%
Upside
Check Pharmacyte Biotech Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$7.0M
EPS (TTM)
0Dividend Yield
0.00%
PE Ratio (TTM)
0.32
Industry PE ratio
0P/B Ratio
0.3229
PEG Ratio
0Return On Equity TTM
67.08%
Track how Pharmacyte Biotech Inc P/E has moved over time to understand its valuation trends.
Pharmacyte Biotech Inc in the last 5 years
Lowest (1.04x)
April 30, 2025
Industry (0.00x)
September 13, 2025
Today (0.32x)
September 13, 2025
Highest (2.13x)
January 31, 2025
Today’s Price to Earnings Ratio: 0.32x
Compare market cap, revenue, PE, and other key metrics of Pharmacyte Biotech Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
$7.0M | NA | 0.32 | 0.00% | ||
BUY | $61.1B | 280.5% | -505.15 | -12.96% | |
NA | $37.7B | NA | NA | -3.89% | |
BUY | $101.2B | 54.04% | 28.08 | 31.86% | |
BUY | $59.4B | 2.03% | 14.11 | 31.37% |
The Pharmacyte Biotech Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Pharmacyte Biotech Inc investment value today
Current value as on today
₹59,852
Returns
Returns from Pharmacyte Biotech Inc Stock
Dollar Returns*
₹5,115 (+5.12%)
Based on 6 analysts
0.00%
Buy
50.00%
Hold
50.00%
Sell
Search interest for Pharmacyte Biotech Inc Stock has increased by 5% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:5% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 7 days, PMCB stock has moved up by 11.6%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 120.4%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 125.6% return, outperforming this stock by 185.5%
Organisation | Pharmacyte Biotech Inc |
Headquarters | 3960 Howard Hughes Parkway, Las Vegas, NV, United States, 89169 |
Industry | Consumer Sundries |
CEO | Mr. Joshua N. Silverman |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Carlos A. Trujillo CPA, CPA | Chief Financial Officer |
Dr. Jose L. Iglesias M.D. | Consulting Chief Medical Officer |
Dr. Hans-Peter Hammes M.D. | Member of Medical & Scientific Advisory Board and Consultant |
Mr. Joshua N. Silverman | Interim CEO, Interim President & Interim Chairman |
Pharmacyte Biotech Inc share price today is $1.04 as on at the close of the market. Pharmacyte Biotech Inc share today touched a day high of $1.07 and a low of $1.03.
Pharmacyte Biotech Inc share touched a 52 week high of $2.42 on and a 52 week low of $0.8 on . Pharmacyte Biotech Inc stock price today i.e. is closed at $1.04,which is 57.08% down from its 52 week high and 30.00% up from its 52 week low.
Pharmacyte Biotech Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Pharmacyte Biotech Inc (PMCB) shares with as little as ₹88.25 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.50 in Pharmacyte Biotech Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Pharmacyte Biotech Inc share’s latest price of $1.04 as on September 13, 2025 at 1:29 am IST, you will get 9.6154 shares of Pharmacyte Biotech Inc. Learn more about
fractional shares .